🇺🇸 FDA
Patent

US 7709515

Compositions comprising ether compounds and pharmaceutical uses therefor

granted A61PA61P1/18A61P13/12

Quick answer

US patent 7709515 (Compositions comprising ether compounds and pharmaceutical uses therefor) held by Esperion Therapeutics, Inc. expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/18, A61P13/12, A61P15/10, A61P25/28